Stanford

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Childhood cancers
• Thyroid cancer

Running trials

• Active, not recruiting

  A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

  NCT03690388· Phase 3· Exelixis· Source